The Invisible Error: Uncovering the Hidden Harm in Blood Testing
In the world of healthcare, where precision and accuracy are paramount, an invisible error has been lurking, causing harm to patients across the NHS. Kevin Moore, a chief medical officer, sheds light on a process failure that has gone unnoticed for far too long.
The Routine That Hides Mistakes
Every blood test, from the moment a needle pierces the skin to the final result, is a carefully choreographed dance. Yet, within this routine, errors creep in, often unnoticed, and their impact is far-reaching. The problem, as Moore highlights, is not hidden away but right in front of us, lurking in the mundane: the phlebotomy trolley, the barcode printer, and the unlabeled tubes.
Pre-Analytical Pitfalls
Research by Plebani reveals a startling truth: up to 70% of errors in laboratory diagnostics occur before the sample even reaches the analyzer. These pre-analytical mistakes, which include patient preparation, sample collection, transport, and processing, are the real culprits. The lab, it seems, is taking the blame for errors it didn't commit.
A Billion Tests, a Billion Opportunities for Error
In England, pathology laboratories conduct over a billion tests annually, an astonishing figure that equates to roughly 20 tests per person. Even a small error rate at the pre-analytical stage, when multiplied by this volume, results in an extraordinary burden of harm. Poorly applied or illegible barcodes, for instance, lead to a significant number of tubes being pulled from the analyzer, introducing delays and further opportunities for mistakes.
The Human Element: Misidentification and Beyond
Misidentification of samples is a critical issue. While it may occur relatively infrequently, in time-pressured environments like hospital wards and emergency rooms, an error rate of 0.5-1% poses a significant risk. For a teaching hospital bleeding 300 patients daily, this translates to approximately two incorrect results daily, potentially leading to patients receiving the wrong treatment or none at all.
Moreover, the harm extends beyond misidentification. Blood, a perishable substance, has a narrow processing window. Delays can cause potassium levels to leak from red blood cells, leading to inaccurate readings and potentially dangerous conditions being missed.
The Irony of Precision
The irony is stark: the NHS has invested heavily in analytical phase precision, with modern laboratory analyzers achieving error rates as low as 0.0001%. These machines process thousands of samples hourly with near-perfect reproducibility. However, their precision is rendered meaningless when the sample itself is flawed.
A Whole-Journey Approach
Recognizing this crisis, the NHS's Getting It Right First Time (GIRFT) program has mandated a whole-journey view of diagnostics. Its national pathology report extends quality frameworks to the pre-analytical and post-analytical stages. Hospitals within the North Central London Integrated Care Board have implemented digital integration at the point of care, eliminating central-printer problems and ensuring accurate, timely labeling.
The Path to Diagnostic Safety
The path to diagnostic safety lies not in more sophisticated analyzers but in addressing the errors at their source: the phlebotomist's trolley, the bedside label printer, and the digital thread connecting every step of the process. Until this thread is in place, laboratories will continue to bear the brunt of errors they didn't cause, and patients will continue to suffer the consequences.
This issue, while complex, highlights the need for a holistic approach to healthcare processes. By addressing the invisible errors, we can ensure that patients receive the accurate, timely care they deserve.
